Oric Pharmaceuticals
Archana Akalkotkar is an accomplished professional in the field of Analytical Sciences, currently serving as Associate Director at ORIC Pharmaceuticals Inc. since May 2022. Prior experience includes roles as Sr. Manager of Analytical Chemistry CMC at BioDuro-Sundia, and as a Sr. Scientist in Analytical Chemistry, where Archana developed and optimized methods for various assays and performed analytical testing supporting GMP campaigns. At Charles River Laboratories, Archana acted as a Research Scientist II, leading nonclinical research studies and authoring over 400 reports and studies. Prior positions also include a Postdoctoral Associate at the University of Louisville, a Scientist at Epitogenesis, and various trainee roles, focusing on formulation optimization and the development of pharmaceutical systems. Archana holds a PhD in Pharmaceutical Sciences from Mercer University and a Bachelor of Science in Pharmacy from The Maharaja Sayajirao University of Baroda.
This person is not in the org chart
This person is not in any offices
Oric Pharmaceuticals
ORIC Pharmaceuticals is a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms of resistance. ORIC's lead asset, ORIC-101, is a potent and selective small-molecule antagonist of the glucocorticoid receptor. ORIC's pipeline targets other undisclosed mechanisms of oncology therapy resistance. ORIC's scientific founders are Drs. Charles Sawyers, MD, and Scott Lowe, PhD, who have strong records of discovering innovative treatments and targets in cancer. The company has assembled strong leadership and scientific teams and a board with extensive experience in drug development and financing. ORIC is funded by leading biotechnology investors, including The Column Group, Topspin Partners, OrbiMed Advisors, EcoR1 Capital, Fidelity Management & Research Company, Trinitas Capital, Foresite Capital, Taiho Ventures, Memorial Sloan Kettering, Kravis Investment Partners, NS Investment and City Hill Ventures. ORIC is headquartered in South San Francisco, California.